Main Postoperative Complications After COVID-19

Main Postoperative Complications After SARS-CoV-2 Infection: A Prospective Cohort Study

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT05694949

Enrollment

100000

Registered

2023-01-23

Start date

2023-02-01

Completion date

2024-02-01

Last updated

2023-01-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Fractures, Bone, Intestines Cancer, Liver Cancer, Pulmonary Cancer, Trauma

Brief summary

To explore the relationship between SARS-CoV-2 infection in different time before operation and postoperative main complications (mortality, main pulmonary and cardiovascular complications) 30 days after operation; To determine the best timing of surgery after SARS-CoV-2 infection.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Age≥18 years; * Patients undergoing any type of elective or confine surgery in operating room; * Informed consent.

Exclusion criteria

* Surgery under local anesthesia (without participation of anesthetist) * Surgery outside the operating room, such as gastrointestinal endoscopy, puncture biopsy, etc * Patients who cannot determine whether they have had SARS CoV-2 infection before surgery * Participating in conflicting clinical study

Design outcomes

Primary

Measure	Time frame	Description
All-cause mortality at 30 days after operation	30 days after surgery	All-cause mortality at 30 days after operation

Secondary

Measure	Time frame	Description
Main pulmonary complications at 30 days after operation	30 days after surgery	a composite of postoperative pneumonia, acute respiratory distress syndrome (ARDS) and unexpected ventilation
Major Adverse Cardiovascular Events (MACE)	30 days after surgery	a composite of myocardial infarction, new-onset heart failure or cardiogenic shock, deep vein thrombosis (DVT), pulmonary embolism (PE), and cerebrovascular accident (CVA)

Contacts

Primary ContactDiansan Su, MD,PHD

diansansu@yahoo.com+8618616514088

Outcome results